News | December 22, 2021
World Health Organisation SAGE recommends use of Novavax Covid-19 vaccine as booster
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies
The company is now ready to offer clinical testing anywhere in the world after early case studies conducted in Israel have demonstrated recovery within 48 hours
The interim results of Phase 3 clinical trials conducted by CanSinoBIO demonstrated that Convidecia has an efficacy of 95.47% at preventing severe disease 14 days after single-dose vaccination.
Researchers observed that the Pfizer/BioNTech and Moderna vaccines were 78% and 73% effective in preventing Covid-19 infections, respectively
Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE
_256_384.jpg)
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
The programme will be implemented across 13 states and benefit 256 min
Subscribe To Our Newsletter & Stay Updated
